su Jingshyh S 4
4 · BeiGene, Ltd. · Filed Apr 4, 2018
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
su Jingshyh S
Director
Transactions
- Award
Share Option (Right to Buy)
2018-04-02+63,290→ 63,290 totalExercise: $12.72Exp: 2028-04-01→ Ordinary Shares (63,290 underlying)
Footnotes (2)
- [F1]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share ("ADS") represents 13 Ordinary Shares.
- [F2]The option shall become exercisable in equal installments on the first, second and third anniversary of the grant date and shall become exercisable in full on the date of the third annual meeting of shareholders following the grant date. All vesting shall cease if the reporting person resigns from the board or otherwise ceases to serve as a director, unless the board determines that the circumstances warrant the continuation of vesting.